These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

798 related items for PubMed ID: 17177200

  • 1. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
    Eggener SE, Carver BS, Loeb S, Kondagunta GV, Bosl GJ, Sheinfeld J.
    Cancer; 2007 Feb 01; 109(3):528-35. PubMed ID: 17177200
    [Abstract] [Full Text] [Related]

  • 2. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
    Carver BS, Shayegan B, Serio A, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Clin Oncol; 2007 Mar 20; 25(9):1033-7. PubMed ID: 17261854
    [Abstract] [Full Text] [Related]

  • 3. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS, Shayegan B, Eggener S, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Clin Oncol; 2007 Oct 01; 25(28):4365-9. PubMed ID: 17906201
    [Abstract] [Full Text] [Related]

  • 4. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F, Gleave ME, Coppin CM, Murray N, Sullivan LD.
    Cancer; 1996 Aug 01; 78(3):480-6. PubMed ID: 8697394
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.
    Coogan CL, Foster RS, Rowland RG, Bihrle R, Smith ER, Einhorn LH, Roth BJ, Donohue JP.
    Urology; 1997 Dec 01; 50(6):957-62. PubMed ID: 9426730
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
    Djaladat H, Nichols C, Daneshmand S.
    Ann Surg Oncol; 2012 Jul 01; 19(7):2388-93. PubMed ID: 22395993
    [Abstract] [Full Text] [Related]

  • 12. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer.
    Spiess PE, Brown GA, Liu P, Tannir NM, Tu SM, Evans JG, Czerniak B, Kamat AM, Pisters LL.
    Cancer; 2006 Oct 01; 107(7):1483-90. PubMed ID: 16944541
    [Abstract] [Full Text] [Related]

  • 13. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A, Tavernier E, Boyle H, Meeus P, Rivoire M, Droz JP.
    BJU Int; 2010 Sep 01; 106(6):779-85. PubMed ID: 20089110
    [Abstract] [Full Text] [Related]

  • 14. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF, Winkler M, Savage P, Seckl MJ, Christmas TJ.
    BJU Int; 2007 Oct 01; 100(4):809-12. PubMed ID: 17711512
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors.
    Carver BS, Serio AM, Bajorin D, Motzer RJ, Stasi J, Bosl GJ, Vickers AJ, Sheinfeld J.
    J Clin Oncol; 2007 Dec 10; 25(35):5603-8. PubMed ID: 17998544
    [Abstract] [Full Text] [Related]

  • 19. Retroperitoneal lymph node dissection after chemotherapy.
    Winter C, Raman JD, Sheinfeld J, Albers P.
    BJU Int; 2009 Nov 10; 104(9 Pt B):1404-12. PubMed ID: 19840021
    [Abstract] [Full Text] [Related]

  • 20. [Clinical study of retroperitoneal lymph node dissection for patients with advanced germ cell tumors].
    Okamura K, Yuba H, Nishimura T, Mizutani K, Takashi M, Gotoh M, Ono Y, Ohshima S.
    Hinyokika Kiyo; 1999 Feb 10; 45(2):95-101. PubMed ID: 10212781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.